Patents by Inventor Hyejun Seo

Hyejun Seo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240165216
    Abstract: A recombinant Mycobacterium strain co-expressing MIF and IL-7, and a composition containing the strain as an active ingredient are disclosed. The strain and the composition are suitable for preventing or treating cancer. The strain induces a maximized anticancer immune response by stably expressing MIF and IL-7 through a mycobacteria-derived replicable plasmid, such as a pMyong2 shuttle vector. Accordingly, the strain and the composition may be usefully used as an efficient anticancer live vaccine composition that induces multiple cellular and humoral immune responses through single administration of the recombinant strain.
    Type: Application
    Filed: March 21, 2022
    Publication date: May 23, 2024
    Applicant: CLIPSBNC CO., LTD.
    Inventors: Bum-Joon KIM, Dong Ho AHN, Hyein JEONG, Hyejun SEO, Jae Hee KIM
  • Publication number: 20240033338
    Abstract: An aspect provides a vaccine composition for preventing tuberculosis comprising chorismate mutase. The vaccine composition alone may induce immunity specific to Mycobacterium tuberculosis, and when provided together with an immune adjuvant, the vaccine composition may induce immunity specific to tuberculosis more effectively. Furthermore, when an existing vaccine for tuberculosis is used as a prime and the vaccine composition according to an aspect including chorismite mutase is provided as a booster, the immunity specific to tuberculosis may be induced significantly more effectively.
    Type: Application
    Filed: August 12, 2021
    Publication date: February 1, 2024
    Applicant: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Bum Joon Kim, Byoung Jun Kim, Jaehun Oh, Hyejun Seo